Published in Obesity and Diabetes Week, October 10th, 2005
Currently marketed outside the United States, the Afinion system offers tests for a variety of medical conditions. In July, the Afinion system and first test, hemoglobin A1c (HbA1c), which is used in monitoring glycemic control in patients with diabetes, received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Under the terms of the agreement, Abbott was appointed as exclusive distributor of the Afinion instrument and test cartridges...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.